- CA$2.47bn
- CA$2.33bn
- CA$1.86m
- 59
- 28
- 99
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15.5 | 14.4 | 20 | 8.97 | 1.85 |
Cost of Revenue | |||||
Gross Profit | 1.11 | 4.15 | 7.28 | 4.15 | -1.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 34.5 | 27.3 | -1.57 | -7.08 | -90.6 |
Operating Profit | -19 | -12.9 | 21.6 | 16 | 92.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -23.5 | -17.1 | 17 | 10.3 | 87 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.1 | -16.3 | 19 | 12.6 | 89.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -18.1 | -16.3 | 19 | 14.4 | 90.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.1 | -16.3 | 19 | 14.4 | 90.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.03 | -0.025 | 0.024 | 0.015 | 0.106 |